End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
4.24
CNY
|
+0.24%
|
|
-1.17%
|
+32.92%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,878
|
3,830
|
2,295
|
1,591
|
1,443
|
4,716
|
Enterprise Value (EV)
1 |
3,094
|
3,995
|
2,935
|
2,955
|
2,696
|
3,857
|
P/E ratio
|
18.5
x
|
-7.16
x
|
-1.88
x
|
-2.24
x
|
-1.93
x
|
53.2
x
|
Yield
|
0.49%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.69
x
|
2.64
x
|
2.15
x
|
2.04
x
|
3.43
x
|
12.9
x
|
EV / Revenue
|
1.82
x
|
2.76
x
|
2.75
x
|
3.79
x
|
6.4
x
|
10.5
x
|
EV / EBITDA
|
9.71
x
|
24.8
x
|
-5.51
x
|
-10.9
x
|
-5.58
x
|
-49.4
x
|
EV / FCF
|
-11.6
x
|
-146
x
|
-10.8
x
|
11.7
x
|
5.24
x
|
5.23
x
|
FCF Yield
|
-8.65%
|
-0.69%
|
-9.3%
|
8.56%
|
19.1%
|
19.1%
|
Price to Book
|
0.9
x
|
1.46
x
|
1.74
x
|
19.4
x
|
-2.15
x
|
17.3
x
|
Nbr of stocks (in thousands)
|
705,306
|
704,033
|
704,033
|
704,033
|
704,033
|
1,478,470
|
Reference price
2 |
4.080
|
5.440
|
3.260
|
2.260
|
2.050
|
3.190
|
Announcement Date
|
4/23/19
|
6/22/20
|
4/29/21
|
4/29/22
|
4/25/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,700
|
1,449
|
1,066
|
780
|
421.1
|
366.8
|
EBITDA
1 |
318.5
|
160.8
|
-532.6
|
-270.9
|
-483.1
|
-78.05
|
EBIT
1 |
230.1
|
91.72
|
-584.2
|
-308.8
|
-508.2
|
-101
|
Operating Margin
|
13.53%
|
6.33%
|
-54.82%
|
-39.59%
|
-120.68%
|
-27.54%
|
Earnings before Tax (EBT)
1 |
178.3
|
-507.9
|
-1,200
|
-731.7
|
-745.7
|
82.92
|
Net income
1 |
153.7
|
-537.6
|
-1,215
|
-709.4
|
-745.4
|
82.57
|
Net margin
|
9.04%
|
-37.09%
|
-114.05%
|
-90.95%
|
-177.04%
|
22.51%
|
EPS
2 |
0.2200
|
-0.7600
|
-1.730
|
-1.010
|
-1.060
|
0.0600
|
Free Cash Flow
1 |
-267.6
|
-27.38
|
-272.8
|
253
|
514.6
|
737.3
|
FCF margin
|
-15.74%
|
-1.89%
|
-25.61%
|
32.44%
|
122.2%
|
201.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
892.96%
|
Dividend per Share
2 |
0.0200
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/23/19
|
6/22/20
|
4/29/21
|
4/29/22
|
4/25/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
217
|
165
|
640
|
1,364
|
1,252
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
859
|
Leverage (Debt/EBITDA)
|
0.6806
x
|
1.024
x
|
-1.202
x
|
-5.036
x
|
-2.592
x
|
-
|
Free Cash Flow
1 |
-268
|
-27.4
|
-273
|
253
|
515
|
737
|
ROE (net income / shareholders' equity)
|
4.9%
|
-18.5%
|
-63.1%
|
-86.8%
|
251%
|
-396%
|
ROA (Net income/ Total Assets)
|
2.55%
|
1.17%
|
-9.24%
|
-6.76%
|
-21.4%
|
-4.11%
|
Assets
1 |
6,025
|
-45,764
|
13,147
|
10,502
|
3,481
|
-2,007
|
Book Value Per Share
2 |
4.520
|
3.730
|
1.870
|
0.1200
|
-0.9600
|
0.1800
|
Cash Flow per Share
2 |
1.760
|
1.430
|
1.020
|
0.0600
|
0.2200
|
0.3400
|
Capex
1 |
47.9
|
135
|
82.7
|
8.76
|
25.7
|
34.6
|
Capex / Sales
|
2.82%
|
9.29%
|
7.76%
|
1.12%
|
6.1%
|
9.44%
|
Announcement Date
|
4/23/19
|
6/22/20
|
4/29/21
|
4/29/22
|
4/25/23
|
3/18/24
|
|
1st Jan change
|
Capi.
|
---|
| +32.92% | 866M | | +2.56% | 101B | | -1.20% | 65.99B | | +47.62% | 41.98B | | +15.99% | 38.65B | | +4.25% | 32.16B | | +8.78% | 19.21B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|